Baxter’s Patent on H1N1-Releasing Deadly Viruses-Part 1
Under patent number US 2009/0060950 A1 Baxter Pharmaceutical company know as Baxter Healthcare Corporation in the USA applied for and received a patent on the Swine Flu Vaccine for H1N1 and many other “swine” “bird” “human” virus diseases to come by the inventors of the swine viral vaccine from Austria. Initially they had commenced the patents in 2007 well before the outbreak of the swine flu virus.
Swine Flu Genetically Engineered Pandemic
NEWS RELEASE
Release: No. H1N1-15=6
Date Mailed: April 25, 2009
For Immediate Release
Contact: Jackie Lindenbach—208/265-8065; 800/336-9266
H1N1-H5N1 Flu Outbreak Implicates Anglo-American
“Vaccine Pipeline” Says Expert Dr. Leonard Horowitz
Los Angeles, CA— Skyrocketing stock values of Novavax, Inc.,1 precipitated by dozens of flu deaths in Mexico, implicates a leading Anglo-American network of genetic engineers in a conspiracy to commit genocide, according to a Harvard trained expert in emerging diseases, Dr. Leonard Horowitz.
Dr. James S. Robertson, England’s leading bio engineer of flu viruses for the vaccine industry, and avid promoter of U.S. Government funding for lucrative “bio defense” contracts, along with collaborators at the US Centers for Disease Control & Prevention (CDC), helped Novavax, Inc., in Bethesda, Maryland, produce genetically-modified recombinants of the avian, swine, and Spanish flu viruses, H5N1 and H1N1, nearly identical to the unprecedented Mexican virus that has now spread to the United States. The outbreak was precisely timed to promote the company’s new research and huge vaccine stockpiling contracts, according to Dr. Horowitz.2....continued
The Swine Flu Panic of 2009
Swine flu kept the world in suspense for almost a year. A massive vaccination campaign was mounted to put a stop to the anticipated pandemic. But, as it turned out, it was a relatively harmless strain of the flu virus. How, and why, did the world overreact? A reconstruction. By SPIEGEL staff.
Excerpt:
None of these diseases receives more attention than influenza. Researchers in more than 130 laboratories in 102 countries are constantly on the lookout for new flu pathogens. Entire careers and institutions, and a lot of money, depend on the outcomes of their work. "Sometimes you get the feeling that there is a whole industry almost waiting for a pandemic to occur," says flu expert Tom Jefferson, from an international health nonprofit called the Cochrane Collaboration. "And all it took was one of these influenza viruses to mutate to start the machine grinding."
Now turned up, the machinery was set into motion. Researchers got to work examining the molecular structure of the virus. The pharmaceutical industry started to develop vaccines. Government agencies laid out disaster plans. There was only one thing that everyone was ignoring: The new pathogen was, in fact, relatively harmless.
April 24, 2009 : WHO Headquarters in Geneva
Shortly after midnight Keiji Fukuda, an influenza specialist with the World Health Organization (WHO), received a phone call from Nancy Cox, the chief of the influenza division at the United States Centers for Disease Control (CDC) in Atlanta.
Fukuda and Cox had once worked together to fight the Asian bird flu. Both scientists remembered all too well how the aggressive killer surfaced in Hong Kong. A third of those infected with the virus died. To this day, Fukuda retains the fear that a similar pathogen could permanently make the jump to humans.
More on our vaccine page.
0 comments:
Post a Comment